vs

Side-by-side financial comparison of CME Group (CME) and LPL Financial Holdings Inc. (LPLA). Click either name above to swap in a different company.

LPL Financial Holdings Inc. is the larger business by last-quarter revenue ($4.9B vs $1.9B, roughly 2.6× CME Group). LPL Financial Holdings Inc. runs the higher net margin — 6.1% vs 0.1%, a 6.0% gap on every dollar of revenue. On growth, LPL Financial Holdings Inc. posted the faster year-over-year revenue change (40.4% vs 14.5%). Over the past eight quarters, LPL Financial Holdings Inc.'s revenue compounded faster (32.0% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

LPL Financial Holdings Inc. was founded in 1989 and is considered the largest independent broker-dealer in the United States. As of 2021 the company had more than 17,500 financial advisors, over US$1 trillion in advisory and brokerage assets, and generated approximately $10.3 billion in annual revenue for the 2023 fiscal year. LPL Financial has main offices in Boston, Fort Mill, Austin, and San Diego. The company is a member of FINRA and the SIPC.

CME vs LPLA — Head-to-Head

Bigger by revenue
LPLA
LPLA
2.6× larger
LPLA
$4.9B
$1.9B
CME
Growing faster (revenue YoY)
LPLA
LPLA
+26.0% gap
LPLA
40.4%
14.5%
CME
Higher net margin
LPLA
LPLA
6.0% more per $
LPLA
6.1%
0.1%
CME
Faster 2-yr revenue CAGR
LPLA
LPLA
Annualised
LPLA
32.0%
10.8%
CME

Income Statement — Q1 2026 vs Q4 2025

Metric
CME
CME
LPLA
LPLA
Revenue
$1.9B
$4.9B
Net Profit
$1.2M
$300.7M
Gross Margin
Operating Margin
0.1%
8.1%
Net Margin
0.1%
6.1%
Revenue YoY
14.5%
40.4%
Net Profit YoY
20.7%
11.1%
EPS (diluted)
$3.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
LPLA
LPLA
Q1 26
$1.9B
Q4 25
$1.6B
$4.9B
Q3 25
$1.5B
$4.6B
Q2 25
$1.7B
$3.8B
Q1 25
$1.6B
$3.7B
Q4 24
$1.5B
$3.5B
Q3 24
$1.6B
$3.1B
Q2 24
$1.5B
$2.9B
Net Profit
CME
CME
LPLA
LPLA
Q1 26
$1.2M
Q4 25
$1.2B
$300.7M
Q3 25
$908.0M
$-29.5M
Q2 25
$1.0B
$273.2M
Q1 25
$956.2M
$318.6M
Q4 24
$874.6M
$270.7M
Q3 24
$912.8M
$255.3M
Q2 24
$883.2M
$243.8M
Operating Margin
CME
CME
LPLA
LPLA
Q1 26
0.1%
Q4 25
61.8%
8.1%
Q3 25
63.3%
-0.7%
Q2 25
66.7%
9.6%
Q1 25
67.5%
11.4%
Q4 24
62.1%
9.7%
Q3 24
64.6%
11.2%
Q2 24
65.3%
11.3%
Net Margin
CME
CME
LPLA
LPLA
Q1 26
0.1%
Q4 25
71.7%
6.1%
Q3 25
59.1%
-0.6%
Q2 25
60.6%
7.1%
Q1 25
58.2%
8.7%
Q4 24
57.3%
7.7%
Q3 24
57.6%
8.2%
Q2 24
57.6%
8.3%
EPS (diluted)
CME
CME
LPLA
LPLA
Q1 26
Q4 25
$3.24
$3.65
Q3 25
$2.49
$-0.37
Q2 25
$2.81
$3.40
Q1 25
$2.62
$4.24
Q4 24
$2.40
$3.58
Q3 24
$2.50
$3.39
Q2 24
$2.42
$3.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
LPLA
LPLA
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.1B
Total DebtLower is stronger
$3.4B
$7.3B
Stockholders' EquityBook value
$5.3B
Total Assets
$202.0B
$18.5B
Debt / EquityLower = less leverage
1.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
LPLA
LPLA
Q1 26
$2.4B
Q4 25
$4.5B
$1.1B
Q3 25
$2.6B
$1.6B
Q2 25
$2.1B
$4.3B
Q1 25
$1.5B
$1.4B
Q4 24
$3.0B
$1.0B
Q3 24
$2.4B
$1.6B
Q2 24
$1.9B
$1.4B
Total Debt
CME
CME
LPLA
LPLA
Q1 26
$3.4B
Q4 25
$7.3B
Q3 25
$7.5B
Q2 25
$7.2B
Q1 25
$5.7B
Q4 24
$5.5B
Q3 24
$4.4B
Q2 24
$4.4B
Stockholders' Equity
CME
CME
LPLA
LPLA
Q1 26
Q4 25
$28.7B
$5.3B
Q3 25
$28.2B
$5.0B
Q2 25
$27.7B
$5.1B
Q1 25
$27.0B
$3.1B
Q4 24
$26.5B
$2.9B
Q3 24
$28.2B
$2.8B
Q2 24
$27.6B
$2.5B
Total Assets
CME
CME
LPLA
LPLA
Q1 26
$202.0B
Q4 25
$198.4B
$18.5B
Q3 25
$187.1B
$18.0B
Q2 25
$179.9B
$17.5B
Q1 25
$157.8B
$14.0B
Q4 24
$137.4B
$13.3B
Q3 24
$137.8B
$11.9B
Q2 24
$123.4B
$11.5B
Debt / Equity
CME
CME
LPLA
LPLA
Q1 26
Q4 25
1.36×
Q3 25
1.49×
Q2 25
1.41×
Q1 25
1.82×
Q4 24
1.87×
Q3 24
1.60×
Q2 24
1.77×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
LPLA
LPLA
Operating Cash FlowLast quarter
$785.0M
Free Cash FlowOCF − Capex
$613.3M
FCF MarginFCF / Revenue
12.4%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
2.61×
TTM Free Cash FlowTrailing 4 quarters
$-981.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
LPLA
LPLA
Q1 26
Q4 25
$1.1B
$785.0M
Q3 25
$968.1M
$-1.7B
Q2 25
$1.1B
$193.3M
Q1 25
$1.1B
$339.8M
Q4 24
$1.0B
$-178.8M
Q3 24
$1.0B
$209.3M
Q2 24
$776.9M
$-178.9M
Free Cash Flow
CME
CME
LPLA
LPLA
Q1 26
Q4 25
$1.1B
$613.3M
Q3 25
$949.7M
$-1.9B
Q2 25
$1.0B
$56.3M
Q1 25
$1.1B
$220.3M
Q4 24
$991.7M
$-344.3M
Q3 24
$973.2M
$62.3M
Q2 24
$758.7M
$-307.8M
FCF Margin
CME
CME
LPLA
LPLA
Q1 26
Q4 25
66.8%
12.4%
Q3 25
61.8%
-41.1%
Q2 25
61.5%
1.5%
Q1 25
67.1%
6.0%
Q4 24
65.0%
-9.8%
Q3 24
61.4%
2.0%
Q2 24
49.5%
-10.5%
Capex Intensity
CME
CME
LPLA
LPLA
Q1 26
Q4 25
2.0%
3.5%
Q3 25
1.2%
3.1%
Q2 25
1.1%
3.6%
Q1 25
0.9%
3.3%
Q4 24
1.7%
4.7%
Q3 24
1.9%
4.7%
Q2 24
1.2%
4.4%
Cash Conversion
CME
CME
LPLA
LPLA
Q1 26
Q4 25
0.96×
2.61×
Q3 25
1.07×
Q2 25
1.03×
0.71×
Q1 25
1.17×
1.07×
Q4 24
1.16×
-0.66×
Q3 24
1.10×
0.82×
Q2 24
0.88×
-0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

LPLA
LPLA

Other$2.6B53%
Transferred At Point In Time$721.1M15%
Annuities$720.5M15%
Transferred Over Time$510.7M10%
Mutual Fund$271.1M5%
Other Investment$110.2M2%

Related Comparisons